Search Results - "Voppel, Alban E"
-
1
Anomalies in language as a biomarker for schizophrenia
Published in Current opinion in psychiatry (01-05-2020)“…PURPOSE OF REVIEWAfter more than a century of neuroscience research, reproducible, clinically relevant biomarkers for schizophrenia have not yet been…”
Get full text
Journal Article -
2
Speech as a Biomarker for Depression
Published in CNS & neurological disorders drug targets (01-01-2023)“…Depression is a debilitating disorder that at present lacks a reliable biomarker to aid in diagnosis and early detection. Recent advances in computational…”
Get more information
Journal Article -
3
Semantic and Acoustic Markers in Schizophrenia-Spectrum Disorders: A Combinatory Machine Learning Approach
Published in Schizophrenia bulletin (22-03-2023)“…Abstract Background and hypothesis Speech is a promising marker to aid diagnosis of schizophrenia-spectrum disorders, as it reflects symptoms like thought…”
Get full text
Journal Article -
4
Syntactic Network Analysis in Schizophrenia-Spectrum Disorders
Published in Schizophrenia bulletin (22-03-2023)“…Abstract Background Language anomalies are a hallmark feature of schizophrenia-spectrum disorders (SSD). Here, we used network analysis to examine possible…”
Get full text
Journal Article -
5
Natural Language Processing Markers for Psychosis and Other Psychiatric Disorders: Emerging Themes and Research Agenda From a Cross-Linguistic Workshop
Published in Schizophrenia bulletin (22-03-2023)“…Abstract This workshop summary on natural language processing (NLP) markers for psychosis and other psychiatric disorders presents some of the clinical and…”
Get full text
Journal Article -
6
Characterizing Speech Heterogeneity in Schizophrenia-Spectrum Disorders
Published in Journal of psychopathology and clinical science (01-02-2022)“…Schizophrenia-spectrum disorders (SSD) are highly heterogeneous in risk factors, symptom characteristics, and disease course outcome. Although speech anomalies…”
Get full text
Journal Article -
7
To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial
Published in Current controlled trials in cardiovascular medicine (07-02-2020)“…Antipsychotic medication is effective for symptomatic treatment in schizophrenia-spectrum disorders. After symptom remission, continuation of antipsychotic…”
Get full text
Journal Article -
8